HUMACYTE

Humacyte develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products for regenerative medicine and vascular surgery applications; off-the-shelf extracellular matrix tissue products, which are formed in vitro from banked vascular smooth muscle cells and then decellularized to eliminate the risk of rejection; and vascular grafts.

#People #Financial #Event #Website #More

HUMACYTE

Social Links:

Facebook

Twitter

Industry:

Biotechnology Medical Medical Device

Founded:

2004-01-01

Address:

Morrisville, North Carolina, United States

Country:

United States

Website Url:

http://www.humacyte.com

Total Employee:

101+

Status:

Active

Contact:

9193139634

Total Funding:

692.86 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag

Current Advisors List

brady-dougan_image

Brady Dougan Board of Directors @ Humacyte
Board_member
2005-01-01

carrie-cox_image

Carrie Cox Chairman of the Board of Directors @ Humacyte
Board_member
2013-01-01

Current Employees Featured

juliana-l-blum_image

Juliana L. Blum
Juliana L. Blum Co-Founder & Executive Vice President, Strategic Business Operations @ Humacyte
Co-Founder & Executive Vice President, Strategic Business Operations
2019-01-01

laura-e-niklason_image

Laura E. Niklason
Laura E. Niklason Founder & CEO @ Humacyte
Founder & CEO

shamik-parikh_image

Shamik Parikh
Shamik Parikh CMO @ Humacyte
CMO
2022-04-01

dale-a-sander_image

Dale A. Sander
Dale A. Sander Chief Financial Officer and Chief Corporate Development Officer @ Humacyte
Chief Financial Officer and Chief Corporate Development Officer
2021-01-01

bj-scheessele_image

B.J. Scheessele
B.J. Scheessele Chief Commercial Officer @ Humacyte
Chief Commercial Officer
2021-08-01

Founder

juliana-l-blum_image

Juliana L. Blum

laura-e-niklason_image

Laura E. Niklason

Stock Details

Company's stock symbol is NASDAQ:HUMA

Investors List

fresenius-medical-care_image

Key Employee Changes

Date	New article
2022-04-05	Humacyte Expands Leadership Team with Appointment of Shamik Parikh, M.D., as Chief Medical Officer
2021-08-17	Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs

Official Site Inspections

http://www.humacyte.com Semrush global rank: 4.77 M Semrush visits lastest month: 1.94 K

Host Informations
Whois Informations

Loading ...